Big Picture

Americans have been burdened with high prescription drug costs for ages now, a critical issue closely tied to health outcomes. The United States is the global leader in per capita pharmaceutical spending, with 2021 data showing that the average American is U.S. consumers pay $2.78. This price gap is widening as U.S. drug prices increase more rapidly than those in other countries. Introducing a benchmarking system to align U.S. prescription drug prices with those in other countries would break down international barriers to price information, allowing all stakeholders in the pharmaceutical industry to access better data. While the current law does not permit the importation of prescription drugs into the U.S. from other countries (except by manufacturers), benchmarking would still clarify how U.S. prices compare internationally, giving stakeholders stronger grounds to negotiate and secure fairer prices.

Why This Initiative Is Important

Unlike other consumer goods, prescription drugs are essential for those who need them. Most people rely on these medications to maintain their health or well-being. It is unacceptable to force people to compromise their health simply because they cannot afford the medications they need.

By refining the existing regulatory framework and providing patients and their families with more equitable access to affordable medications, this proposal seeks to address the fundamental injustice of the current system. Patients are often the most vulnerable stakeholders in the healthcare system, lacking the negotiation power that providers and pharmaceutical companies have. It is essential to develop solutions that allow them to obtain the medications they need at a reasonable price. Every American deserves access to affordable medication without having to sacrifice their financial security.

Acknowledgment: The opinions expressed in this article are those of the individual author.

Sources

Adams, Ben. “The Top 10 Pharma Drug Ad Spenders for 2022.” Fierce Pharma, 1 May 2023, www.fiercepharma.com/special-reports/top-10-pharma-drug-brand-ad-spenders-2022 . Accessed 26 Aug. 2024.

“An Overview of the Medicare Part D Prescription Drug Benefit.” KFF, 17 Oct. 2023, www.kff.org/medicare/fact-sheet/an-overview-of-the-medicare-part-d-prescription-drug-benefit/#:~:text=Published:%20Oct%2017%2C%202023 . Accessed 26 Aug. 2024.

Bosworth, Arielle. “Changes in the List Prices of Prescription Drugs, 2017-2023.” ASPE, 6 Oct. 2023, aspe.hhs.gov/reports/changes-list-prices-prescription-drugs#:~:text=Over%20the%20period%20from%20January . Accessed 26 Aug. 2024.

“Brand Name (Drugs) – HealthCare.gov Glossary.” HealthCare.gov, www.healthcare.gov/glossary/brand-name-drugs/#:~:text=A%20drug%20sold%20by%20a . Accessed 26 Aug. 2024.

Conrad, Ryan, and Randall Lutter. Generic Competition and Drug Prices: New Evidence Linking Greater Generic Competition and Lower Generic Drug Prices Authors Affiliations. Dec. 2019, www.fda.gov/media/133509/download#:~:text=With%20two%20competitors%2C%20AMP%20data . Accessed 26 Aug. 2024.

Division (DCD), Digital Communications. “What Is the Affordable Care Act?” HHS.gov, www.hhs.gov/answers/health-insurance-reform/what-is-the-affordable-care-act/index.html#:~:text=The%20%E2%80%9CAffordable%20Care%20Act%E2%80%9D%20( . Accessed 26 Aug. 2024.

Eisley, Abigail. “How the ACA Has Affected Prescription Access and Affordability.” GoodRx, GoodRx, 20 June 2022, www.goodrx.com/hcp-articles/providers/aca-impact-prescription-access . Accessed 26 Aug. 2024.

FDA. “Generic Drugs: Questions & Answers.” FDA, Mar. 2021, www.fda.gov/drugs/frequently-asked-questions-popular-topics/generic-drugs-questions-answers . Accessed 26 Aug. 2024.

​​Hausman, Sandy. Why Are U.S. Prescription Drug Prices so High? www.commonwealthfund.org/sites/default/files/documents/___media_files_multimedia_podcasts_cmwf_podcast_transcript_rxdrugs.pdf . Accessed 26 Aug. 2024.

​​Kaiser Family Foundation. “Status of State Medicaid Expansion Decisions: Interactive Map.” KFF, 7 Feb. 2024, www.kff.org/affordable-care-act/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map /. Accessed 26 Aug. 2024.

Kurani, Nisha, et al. “How Do Prescription Drug Costs in the United States Compare to Other Countries?” Peterson-KFF Health System Tracker, 8 Feb. 2022, www.healthsystemtracker.org/chart-collection/how-do-prescription-drug-costs-in-the-united-states-compare-to-other-countries/ . Accessed 26 Aug. 2024.

MacKrill, Kate, et al. “The Effect of Rebranding Generic Medicines on Drug Efficacy and Side Effects.” Psychology & Health, vol. 34, no. 12, May 2019, pp. 1470–85, https://doi.org/10.1080/08870446.2019.1616088 . Accessed 26 Aug. 2024.

Mikulic, Matej. “Top Pharma Markets by Country Market Share 2018.” Statista, 24 Mar. 2023, www.statista.com/statistics/245473/market-share-of-the-leading-10-global-pharmaceutical-markets/ . Accessed 26 Aug. 2024.

Mulcahy, Andrew W., et al. “International Prescription Drug Price Comparisons: Estimates Using 2022 Data.” Www.rand.org, 1 Feb. 2024, www.rand.org/pubs/research_reports/RRA788-3.htm l. Accessed 27 Aug. 2024.

NASHP. “Drug Price Transparency Laws Position States to Impact Drug Prices.” NASHP, 10 Jan. 2022, nashp.org/drug-price-transparency-laws-position-states-to-impact-drug-prices /. Accessed 26 Aug. 2024.

NASHP. “Prescription Drug Pricing Transparency Law Comparison Chart.” NASHP, 1 Nov. 2021, nashp.org/state-tracker/prescription-drug-pricing-transparency-law-comparison-chart/#:~:text=A%20number%20of%20states%20have . Accessed 26 Aug. 2024.

Office of Communications. Medicare. 2016, www.ssa.gov/pubs/EN-05-10043.pdf . Accessed 26 Aug. 2024.

“Out-of-Pocket Maximum/Limit – HealthCare.gov Glossary.” HealthCare.gov, 2019, www.healthcare.gov/glossary/out-of-pocket-maximum-limit/ . Accessed 26 Aug. 2024.

Pestaina, Kaye, and Catherine Stamm. “Prescription Drug Importation Gets Renewed Attention.” Www.mercer.com, 21 Feb. 2020, www.mercer.com/en-us/insights/law-and-policy/prescription-drug-importation-gets-renewed-attention/ . Accessed 27 Aug. 2024.

“Pharmaceutical Spending.” OECD, 2024, www.oecd.org/en/data/indicators/pharmaceutical-spending.html#:~:text=2021 . Accessed 29 Aug. 2024.

“Pharmaceutical Spending per Capita by Country 2018 | Statista.” Statista, Statista, 2018, www.statista.com/statistics/266141/pharmaceutical-spending-per-capita-in-selected-countries/ . Accessed 26 Aug. 2024.

“Prescription Drug Prices in the U.S. Are 2.78 Times Those in Other Countries.” Www.rand.org, www.rand.org/news/press/2024/02/01.html . Accessed 27 Aug. 2024.

“Prescription Drugs and Over-The-Counter (OTC) Drugs: Questions and Answers.” FDA, Apr. 2019, www.fda.gov/drugs/frequently-asked-questions-popular-topics/prescription-drugs-and-over-counter-otc-drugs-questions-and-answers . Accessed 26 Aug. 2024.

“Prescription Drugs: Medicare Spending on Drugs with Direct-To-Consumer Advertising.” Gao.gov, 2021, www.gao.gov/products/gao-21-380#:~:text=Highlights . Accessed 26 Aug. 2024.